Clinical and pharmacological group: & nbsp

Immunoglobulins

Included in the formulation
  • Lactoglobulin antiliprotite cow
    lyophilizate inwards 
  • АТХ:

    J.06.B.C   Other immunoglobulins

    Pharmacodynamics:

    Has antibacterial effect. The preparation contains immunoglobulins containing antibodies to pathogenic Proteus vulgaris (serogroup 043) and Proteus mirabilis (serogroup 035) and Escherichia coli (serogroup 026, 055, 0111, 0119).

    Pharmacokinetics:

    Not studied.

    Indications:Used to normalize the intestinal microflora.

    XVI.P75-P78.P78.9   Disorder of digestive system in perinatal period, unspecified

    Contraindications:

    Individual intolerance to cow's milk.

    Carefully:

    Individual intolerance to cow's milk.

    Pregnancy and lactation:

    Pregnancy and lactation: recommendations for FDA - Category A. There are no restrictions to use during pregnancy and lactation.

    Dosing and Administration:

    The drug is applied 30 minutes prior to feeding.

    Newborns: 1 dose 1-2 times a day; 1-6 months: 1 dose 2 times a day; 6 months - 1 year: 2 doses 2 times a day; over 1 year: 2 doses 2-3 times a day.

    The course of treatment is 1-14 days.

    The highest daily dose: 6 doses.

    The highest single dose: 2 doses.

    Side effects:

    Allergic reactions.

    Overdose:

    Not described.

    Interaction:Compatible with any medication. At simultaneous application with bifidumbacterinum efficiency raises.
    Special instructions:It is used as a part of complex etiological therapy against the background of desensitizing drugs.
    Instructions
    Up